BCL2 and leukemia: Further studies are warranted to dissect the regulatory networks sustaining BCL2 overexpression, clarify post-transcriptional mechanisms stabilizing survival proteins, and explore strategies to modulate the immune microenvironment, ultimately improving outcomes in this high-risk leukemia subtype